Suchergebnisse - "Szarvas, Nóra"

PubPharm (7)

1

Fluorescent enzyme-coupled activity assay for phenylalanine ammonia-lyases

enthalten in: Scientific reports | 2020

von Moisă, M. | Amariei, D. | Nagy, E. | +4

2

Validation of RNAi Silencing Efficiency Using Gene Array Data shows 18.5% Failure Rate across 429 Independent Experiments

enthalten in: Molecular therapy. Nucleic acids | 2016

von Munkácsy, G. | Sztupinszki, Z. | Herman, P. | +4

3

Genetic analysis and functional characterization of novel mutations in a series of patients with atypical hemolytic uremic syndrome

enthalten in: Molecular immunology | 2016

von Szarvas, N. | Szilágyi, �. | Csuka, D. | +13

4

Functional characterization of two novel non-synonymous alterations in CD46 and a Q950H change in factor H found in atypical hemolytic uremic syndrome patients

enthalten in: Molecular immunology | 2015

von Mohlin, F. | Nilsson, S. | Levart, T. | +11

5

First-line therapy in atypical hemolytic uremic syndrome : consideration on infants with a poor prognosis

enthalten in: Italian journal of pediatrics | 2014

von Szarvas, N. | Szilágyi, �. | Tasic, V. | +11

6

First-line therapy in atypical hemolytic uremic syndrome: consideration on infants with a poor prognosis

enthalten in: The Italian journal of pediatrics | 2014

von Szarvas, N. | Szilágyi, �. | Tasic, V. | +11

7

First-line therapy in atypical hemolytic uremic syndrome: consideration on infants with a poor prognosis

enthalten in: The Italian journal of pediatrics | 2014

von Szarvas, N. | Szilágyi, �. | Tasic, V. | +11

1
[1]